Localization of the 1,4-dihydropyridine drug acceptor of P-glycoprotein to a cytoplasmic domain using a permanently charged derivative N-methyl dexniguldipine

International Journal of Clinical Pharmacology and Therapeutics

Volumn 38, Issue 3, 2000, Pages 130-140

  Ferry, D ^a   Boer, R ^c   Callaghan, R ^c   Ulrich, W R ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ALTANA PHARMA AG   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

ABC transporter; Dexniguldipine; P glycoprotein

Indexed keywords

1,4 DIHYDROPYRIDINE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; AZIDE; DEXNIGULDIPINE; DIMETHYL SULFOXIDE; GLYCOPROTEIN P; VINBLASTINE;

ANIMAL CELL; ARTICLE; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DRUG ACCUMULATION; DRUG BINDING SITE; DRUG CYTOTOXICITY; DRUG PROTEIN BINDING; DRUG TRANSPORT; MEMBRANE VESICLE; MULTIDRUG RESISTANCE; NONHUMAN; PHOTOAFFINITY LABELING; PROTEIN DOMAIN;

EID: 0034009568     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP38130     Document Type: Article

References (37)

1. Affolter H, Coronado R 1986 Sidedness of reconstituted calcium channels from muscle transverse tubules as determined by D600 and D890 blockade. Biophysics 149: 767-771
2. Bangalore R, Baindur N, Rutledge A, Triggle D, Kass R 1994 L-type calcium channels: Asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines. Mol Pharmacol 46: 660-666
3. 2+ channels and to a subtype of alpha-1-adrenoceptors. Eur J Pharmacol 172: 131-145
4. Borchers C, Ullrich WR, Klemm K, Ise W, Gekler V, Haas S, Schodl A, Conrad J, Przybylski M, Boer R 1995 B2909-005, an azido derivative of the chemosensitiser dexniguldipine-HCl photolabels P-glycoprotein. Mol Pharmacol 48: 21-29
5. Bruggeman EP, Germann UA, Gottesmann MM, Pastan I 1989 Two different regions of phosphoglycoprotein are photoaffinity-labeled by azidopine. J Biol Chem 264: 15483-15488
6. Bruggemann EP, Currier SJ, Gottesman MM, Pastan I 1992 Characterisation of the azidopine and vinblastine binding site of P-glycoprotein. J Biol Chem 267: 21020-21026
7. Choi K, Chen C-J, Kriegler M, Roninson IB 1988 An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene. Cell 53: 519-529
8. Currier SJ, Kane SE, Willingham MC, Cardarelli CO, Pastan I, Gottesman MM 1992 Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters. J Biol Chem 267: 25153-25159
9. Dey S, Ramachandra M, Pastan I, Gottesman MM, Amdubkar S 1997 Evidence for two nonidentical drug interaction sites in human P-glycoprotein. Proc Natl Acad Sci 94: 10594-10599
10. Endicott JA, Ling V 1989 The biochemistry of multidrug resistance. Annu Rev Biochem 58: 137-171
11. 3H]-azidopine. Eur Mol Biol Org J 4: 1933-1940
12. 3H]-vinblastine binding to P-glycoprotein of MCF-7 ADR breast cancer cell membranes. Biochem Pharmacol 76: 112-119
13. 3H]-azidopine. FEBS Lett 169: 112-118
14. Ferry DR, Russell MA, Cullen MH 1992 P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is allosterically coupled to a vinca alkaloid-selective binding site. Biochem Biophys Res Commun 188: 440-445
15. 3H]-Taxol binds to a drug acceptor site which is allosterically coupled to the vinblastine-selective site of P-glycoprotein. Proc Am Assoc Cancer Res 35: 348
16. Gottesman MM, Pastan P 1993 Biochemistry of multidrug-resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427
17. Greenberger LM 1993 Major photoaffinity drug-labelling sites for iodaryl azidoprazosin in P-glycoprotein are within or immediately C-terminal to transmembrane domains six and twelve. J Biol Chem 268: 11417-11425
18. Greenberge, LM, Lisanti CJ, Silva JT, Horwitz SB 1991 Domain mapping of the photoaffinity drug-binding sites in P-glycoprotein encoded by mouse mdr1b. J Biol Chem 266: 20744-20751
19. Hescheler J, Pelzer D, Trube G, Trautwein W 1982 Does the organic calcium channel blocker D600 act from the inside or outside on cardiac cell membranes? Pflügers Arch 393: 287-291
20. Hofmann J, Ueberall F, Egle A, Grunicke H 1991 B-859-35, a new drug with antitumour activity reverses multidrug resistance. Int J Cancer 47: 870-874
21. Hyafil F, Vergely C, Du VP, Grand PT 1993 In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res 53: 4595-4602
22. Kajiji S, Dreslin JA, Grizzuti K, Gros P 1994 Structurally distinct MDR modulators show specific patterns of reversal against P-glycoproteins bearing unique mutations at serine 939/941. Biochemistry 33: 5041-5048
23. Kioka N, Tsubota J, Kakehi Y, Komano T Gottesman MM, Pastan I, Ueda K 1989 P-glycoprotein gene (MDR1) cDNA from human adrenal P-glycoprotein carries Gly 185 with an altered pattern of multidrug resistance. Biochem Biophys Res Commun 162: 224-231
24. Kirk J, Syed K, Harris A, Jarman M, Roufogalis B, Stratford I, Carmichael J 1994 Reversal of P-glycoprotein-mediated multidrug resistance by pure anti-oestrogens and novel tamoxifen derivatives. Biochem Pharmacol 48: 277-285
25. 3H]-vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells. Eur J Pharmacol 288: 105-114
26. Malkhandi PJ, Ferry DR, Boer R, Kerr DJ 1995 P-glycoprotein has a drug acceptor site for 1,4-dihydropyridines which is localised on an intracellular domain. Proc Am Assoc Cancer Res 36: A332
27. Nuessler V, Scheulen ME, Oberneder R, Kreigmair M, Goebel KJ, Rathgeb F, Wurst W, Zech K, Wilmans W 1997 Phase I and pharmacokinetic study of the P-glycoprotein modulator dexniguldipine-HCl. Eur J Med Res 21: 55-61
28. Raviv Y, Poland HB, Bruggermann EP, Pastan I, Gottesman MH 1990 Photosensitive labeling of a functional multidrug transporter in living drug-resistant tumour cells. J Biol Chem 265: 3975-3980
29. Safa AR 1988 Photoaffinity labelling of the multidrug resistance-related P-glycoprotein with photoactive analogues of verapamil. Proc Natl Acad Sci 85: 7187-7191
30. Spoelstra EC, Westerhoff HV, Dekker H, Lankelma J 1992 Kinetics of daunorubicin transport by P-glycoprotein of intact cells. Eur J Biochem 207: 567-579
31. Stein WD, Cardarelli C, Pastan I, Gottesman MH 1994 Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates. Mol Pharmacol 45: 763-772
32. ++ channels. Proc Natl Acad Sci USA 87: 9108-9112
33. 1-subunit. Proc Natl Acad Sci USA 88: 10769-10773
34. Tamai I, Safa AR 1991 Azidopine non-competitively interacts with vinblastine and cyclosporin A binding to p-glycoprotein in multidrug resistant cells. J Biol Chem 266: 16796-16800
35. Valdivia HH, Coronado R 1990 Internal and external effects of dihydropyridines in the calcium channels of skeletal muscle. J Gen Physiol 95: 1-27
36. Xianoping Z, Collins KI, Greenberger LM 1995 Functional evidence that transmembrane 12 and the loop between transmembrane 11 and 12 form part of the drug-binding domain in P-glycoprotein encoded by MDR1. J Biol Chem 270: 5441-5448
37. Yoshimura A, Kuwazuru Y, Sumizawa T, Ichikawa M, Ikeda S, Uda T, Akeyama S 1989 Cytoplasmic orientation and two domain structures of the multidrug transporter P-glycoprotein, demonstrated with sequence-specific antibodies. J Biol Chem 264: 16282-16291